Gubra A/S (GUBRA.CO)

DKK 411.6

(6.85%)

Total Liabilities Summary of Gubra A/S

  • Gubra A/S's latest annual total liabilities in 2023 was 145.62 Million DKK , down -5.87% from previous year.
  • Gubra A/S's latest quarterly total liabilities in 2024 Q1 was 146.88 Million DKK , up 0.87% from previous quarter.
  • Gubra A/S reported annual total liabilities of 154.69 Million DKK in 2022, up 2.68% from previous year.
  • Gubra A/S reported annual total liabilities of 150.66 Million DKK in 2021, up 30.82% from previous year.
  • Gubra A/S reported quarterly total liabilities of 146.88 Million DKK for 2024 Q2, down 0.0% from previous quarter.
  • Gubra A/S reported quarterly total liabilities of 145.62 Million DKK for 2023 FY, down -5.87% from previous quarter.

Annual Total Liabilities Chart of Gubra A/S (2023 - 2019)

Historical Annual Total Liabilities of Gubra A/S (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 145.62 Million DKK -5.87%
2022 154.69 Million DKK 2.68%
2021 150.66 Million DKK 30.82%
2020 115.16 Million DKK 8.28%
2019 106.35 Million DKK 0.0%

Peer Total Liabilities Comparison of Gubra A/S

Name Total Liabilities Total Liabilities Difference
ALK-Abelló A/S 2.27 Billion DKK 93.61%
Bavarian Nordic A/S 4.01 Billion DKK 96.372%
Genmab A/S 3.67 Billion DKK 96.042%
Novo Nordisk A/S 207.92 Billion DKK 99.93%
Orphazyme A/S 5.07 Million DKK -2772.209%
Pharma Equity Group A/S 42.4 Million DKK -243.413%
Zealand Pharma A/S 1.6 Billion DKK 90.933%